GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 13 filers reported holding GAMIDA CELL LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,079 | -46.6% | 29,203 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $56,362 | +138.3% | 29,203 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $23,654 | -37.2% | 29,203 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $37,672 | -24.7% | 29,203 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $50,000 | -3.8% | 29,203 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $52,000 | -57.0% | 29,203 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $121,000 | +63.5% | 29,203 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $74,000 | -35.1% | 29,203 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $114,000 | -51.7% | 29,203 | 0.0% | 0.00% | -60.0% |
| Q1 2021 | $236,000 | -36.2% | 29,203 | -33.9% | 0.01% | -50.0% |
| Q4 2020 | $370,000 | +58.8% | 44,203 | -25.3% | 0.01% | 0.0% |
| Q3 2020 | $233,000 | -8.3% | 59,203 | 0.0% | 0.01% | -9.1% |
| Q2 2020 | $254,000 | +195.3% | 59,203 | +102.7% | 0.01% | +175.0% |
| Q1 2020 | $86,000 | -31.2% | 29,203 | 0.0% | 0.00% | -20.0% |
| Q4 2019 | $125,000 | +3.3% | 29,203 | 0.0% | 0.01% | -16.7% |
| Q3 2019 | $121,000 | – | 29,203 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,287,745 | $27,584,000 | 2.58% |
| Stonepine Capital Management, LLC | 379,470 | $3,184,000 | 2.44% |
| Healthcare Value Capital, LLC | 50,000 | $420,000 | 1.42% |
| BVF INC/IL | 1,343,667 | $11,273,000 | 0.44% |
| Rock Springs Capital Management LP | 2,094,000 | $17,569,000 | 0.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 70,852 | $594,000 | 0.34% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,431,795 | $20,403,000 | 0.33% |
| Atom Investors LP | 217,231 | $1,823,000 | 0.18% |
| MYDA Advisors LLC | 56,000 | $470,000 | 0.14% |
| J. Goldman & Co LP | 314,236 | $2,636,000 | 0.13% |